Dr. Anuj Dilip Patel, MD

Dr. Patel practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Patel's NPI, 1821539149, was assigned on March 20, 2017. Dr. Patel graduated from The Warren Alpert Medical School of Brown University in 2017. Dr. Patel's Texas license number on file is U4897.

Dr. Patel's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Patel's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices. Vendor and product names are available with a free account.

Neurology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Patel is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Patel's licenses on file in 11 states: Texas, Florida, Arizona, Massachusetts, Tennessee, Washington, Georgia, Louisiana, Mississippi, Alabama and Oklahoma.

Dmand AI lists encephalopathy, epilepsy and fibromyalgia and chronic pain among the conditions Dr. Patel treats.

CMS data shows 383 Medicare services from Dr. Patel across 8 procedure codes in 2024, for 234 Medicare patients. Medicare paid $37,625 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 234 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 69, with 53% women.

In 2024, Dr. Patel wrote 193 Medicare Part D claims for 44 patients. 94% of them were for generic drugs. CMS names the drug for 113 of them, across 5 drugs with 11 or more claims each, at $2,337 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dr. Patel graduated from The Warren Alpert Medical School of Brown University in 2017.

Dr. Patel is in network with 4 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. POS plans come from the most carriers, 3. Check the plan with the practice before a visit.